Access cutting-edge peripheral neuropathy treatment through this clinical trial at a research site in Hackensack. Study-provided care at no cost to qualified participants.
Access peripheral neuropathy specialists in Hackensack at no cost
This study follows strict safety protocols and ethical guidelines
All study-related peripheral neuropathy treatment provided free
The goal of this clinical trial is to learn about daratumumab and hyaluronidase-fihj in patients with monoclonal gammopathy of undetermined significant (MGUS) who have been diagnosed with peripheral neuropathy suspected to be cause by paraproteinemia. The main question\[s\] it aims to answer are: • how well does this medication help improve MGUS associated peripheral neuropathy Participants will be asked be asked to get some testing done prior to starting the trial in order for us to assess yo
Sponsor: Georgetown University
Check if you qualify for this peripheral neuropathy clinical trial in Hackensack, NJ
If you're searching for peripheral neuropathy treatment options in Hackensack, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hackensack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced peripheral neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.